2021
|
Invention
|
Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity.
Cannabidiol quino... |
|
Invention
|
Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal ... |
2020
|
Invention
|
Formulations of cannabidiol derivatives and their use as modulators of cannabinoid receptor type ... |
|
Invention
|
2). Compositions, comprising the cannabidiol derivatives of Formula (I) in pharmaceutical formula... |
2019
|
Invention
|
Cannabigerol quinone acid and salts thereof.
A compound of formula I
A compound of formula I
... |
|
Invention
|
Cannabigerol quinone acid and salts thereof. The application relates to a compound of formula (I)... |
2017
|
Invention
|
Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity. Cannabidiol quinol... |
2015
|
Invention
|
Cannabigerol derivatives. The present invention relates to novel cannabigerol quinone derivatives... |
2014
|
Invention
|
Cannabidiol quinone derivatives. The present invention relates to novel cannabidiol quinone deriv... |
2010
|
Invention
|
Cannabinoid quinone derivatives. Cannabinoid quinone derivatives. The present invention refers to... |